LEGAL DISCLAIMER FOR THE GLUCOSENSOR.COM WEBSITE
Please carefully read this Legal Disclaimer for the Website before using the GlucoSensor.com website, operated by Maralvion.
Version: V010726
Effective date: 1 July 2026
Issued by: Maralvion sp. z o.o.
Applicable website: www.glucosensor.com
Applicable product: GlucoSensor™ Q Continuous Glucose Monitoring System, Model D1
IMPORTANT WEBSITE AND SAFETY SUMMARY
S.1 The Website provides general product information, educational content, commercial information, ordering functionality, account functionality, customer support information and product safety communications relating to GlucoSensor™ Q.
S.2 The Website is not a medical service, healthcare service, diagnostic service, treatment service, emergency response service or professional monitoring service.
S.3 The Website does not provide, display, calculate, interpret, monitor or routinely store real time or historical CGM readings, glucose trends, glucose alerts, reports or other medical measurement data generated by the GlucoSensor™ Q App or System.
S.4 Do not use Website content to diagnose, screen for or rule out diabetes, prediabetes, gestational diabetes or any other medical condition, or to make treatment, medication, insulin dosing, diet, exercise or other health related decisions.
S.5 GlucoSensor™ Q is intended for adults aged 18 years and older. Website content does not expand the certified intended purpose, target population, indications, contraindications, warnings or conditions of use stated in the Instructions for Use (IFU), product labelling or mandatory product information.
S.6 Always follow the IFU, product labelling, App warnings, safety notices and the advice of your qualified healthcare professional. Where fingerstick confirmation is required or appropriate, use a conventional blood glucose meter.
S.7 In case of severe symptoms, urgent health concerns or a suspected medical emergency, do not wait for Website information, Website availability, customer support, email, chat, forms or product complaint handling. Seek immediate medical assistance.
S.8 Customer support may assist with product, order, account, technical, replacement, complaint and safety reporting matters, but customer support is not authorised to provide medical advice, diagnosis, treatment guidance, insulin dosing advice or emergency assistance.
S.9 The fact that the Website is accessible in a country, language, search result, advertisement, link or app store environment does not mean that GlucoSensor™ Q is lawfully offered, supplied, supported or suitable in that country.
S.10 This summary does not replace this full Legal Disclaimer, the Website EULA and Terms of Use, the App EULA, the App Legal Disclaimer, the Privacy Policy, the General Delivery Terms, the Returns and Refund Policy, the Sensor Replacement Policy, the IFU, product labelling or mandatory safety information.
ARTICLE 1. PURPOSE AND LEGAL FRAMEWORK
1.1 This Legal Disclaimer applies to the access to and use of the GlucoSensor™ Q Website operated at www.glucosensor.com by Maralvion sp. z o.o.
1.2 It explains important medical, technical, commercial, privacy, safety and legal limitations that apply to Website content, Website account functionality, ordering functionality, support forms, educational materials, product information, customer support information and related Website services.
1.3 This Legal Disclaimer must be read together with the Website EULA and Terms of Use, the App EULA, the App Legal Disclaimer, the Privacy Policy, the Instructions for Use (IFU), product labelling, App warnings, safety notices, the General Delivery Terms, the Returns and Refund Policy, the Sensor Replacement Policy and any other product documentation, Website notice, App notice or safety communication made available in relation to GlucoSensor™ Q.
1.4 In the event of any inconsistency concerning the official intended purpose, target population, indications, contraindications, warnings, precautions, limitations, CE marking, product identification, product performance specifications or mandatory information required for the safe and correct use of GlucoSensor™ Q, the applicable product labelling, mandatory regulatory information, safety notices and IFU shall prevail for that matter only.
1.5 In the event of any inconsistency concerning privacy, data protection, cookies, trackers or the processing of Personal Data, Health Data or other personal information, the Privacy Policy and any applicable cookie notice shall prevail.
1.6 In the event of any inconsistency concerning purchase, payment, delivery, subscriptions, cancellation, returns, refunds, replacement requests, complaints or commercial terms, the General Delivery Terms, the Returns and Refund Policy and the Sensor Replacement Policy shall prevail, as applicable.
1.7 In the event of any inconsistency concerning App use, App licensing, glucose readings, alerts, reports, Share and Follow functionality, App connectivity, App data availability or other App related matters, the App EULA and the App Legal Disclaimer shall prevail, as applicable.
1.8 Questions concerning Website licensing, Website account use, access rights, suspension, termination, governing law, jurisdiction, dispute resolution and general legal terms are governed by the Website EULA and Terms of Use, without prejudice to mandatory rights or protections that apply under the law of your country of residence.
1.9 This Legal Disclaimer does not create or alter the regulatory roles and responsibilities of the Manufacturer, the Authorised Representative or Maralvion under applicable medical device law.
1.10 Nothing in this Legal Disclaimer limits, excludes or replaces any mandatory information, warning, instruction, right, remedy, liability, obligation or protection that applies under mandatory consumer protection law, product liability law, data protection law, medical device law or any other mandatory legal provision.
1.11 Capitalized terms used in this Legal Disclaimer have the meaning given to them in the Website EULA and Terms of Use, the App EULA, the Privacy Policy, the IFU or the applicable legal document, unless the context clearly requires otherwise.
ARTICLE 2. WEBSITE SCOPE AND DISTINCTION FROM THE APP AND SYSTEM
2.1 The Website provides general product information, educational content, commercial information, ordering functionality, account functionality, customer support information, replacement request information, complaint handling channels, product safety communications and related Website services concerning GlucoSensor™ Q.
2.2 The Website is separate from the GlucoSensor™ Q App and from the medical measurement functionality of the GlucoSensor™ Q System.
2.3 The Website does not itself provide continuous glucose monitoring, glucose measurement, medical algorithmic calculation, glucose trend analysis, glucose alerts, glucose reports, Share and Follow functionality, remote patient monitoring, clinical interpretation or any other medical functionality.
2.4 The Website does not provide, display, calculate, interpret, monitor or routinely store real time or historical CGM readings, glucose trends, glucose alerts, reports or other medical measurement data generated by the Sensor, the App or the System.
2.5 Glucose readings, alerts, reports, trends, visualisations, Share and Follow functionality, Sensor communication and measurement related outputs are provided through or in connection with the App and the GlucoSensor™ Q System, subject to the App EULA, the App Legal Disclaimer, the IFU, product labelling, App warnings and safety notices.
2.6 Website tutorials, FAQs, videos or instructions may help users understand general product use, ordering, preparation for use, sensor application, App installation, account setup, troubleshooting, replacement requests, travel, storage or handling, but they do not replace the IFU, product labelling, App warnings or professional medical advice.
2.7 Website educational materials about diabetes, glucose monitoring, glucose variability, nutrition, lifestyle, wellbeing or related topics are general and informational only and are not personalized medical advice or clinical guidance.
2.8 Maralvion may operate Website interface, account, e-commerce, customer support, product communication and non medical information functions within its own role. This does not mean that Maralvion provides an independent medical algorithm, glucose calculation engine, diagnostic service or medical interpretation service through the Website.
ARTICLE 3. PRODUCT INFORMATION, INTENDED PURPOSE AND TERRITORIAL SCOPE
3.1 GlucoSensor™ Q is a CE marked Class IIb Continuous Glucose Monitoring System, Model D1, manufactured by Dreisam and made available by Maralvion under the GlucoSensor™ Q brand in selected European markets.
3.2 The GlucoSensor™ Q System consists of the Sensor and the App. Any description of the System on the Website is a summary for user convenience and commercial information purposes only.
3.3 The certified intended purpose, target population, indications, contraindications, warnings, precautions, limitations, performance specifications and conditions of use are those stated in the applicable IFU, product labelling and applicable regulatory documentation.
3.4 Website descriptions, summaries, advertisements, product pages, FAQs, tutorials, images, videos, blog posts or customer support information do not expand, modify, replace or override the certified intended purpose, IFU, product labelling, App warnings, product safety notices or mandatory regulatory information.
3.5 GlucoSensor™ Q is intended for adults aged 18 years and older. It is not intended for persons under 18 years of age and must not be used by persons under 18 years of age.
3.6 Product information on the Website is intended only for the countries where Maralvion lawfully offers or supplies GlucoSensor™ Q. Website accessibility, advertising visibility, language availability or app store availability in another country does not mean that GlucoSensor™ Q is marketed, supplied, authorised, suitable, lawful or supported in that country.
3.7 If you acquire, import, access, order, install or use GlucoSensor™ Q outside the countries where it is lawfully offered or supplied by Maralvion, you do so on your own initiative and at your own risk and are responsible for ensuring compliance with applicable local laws and requirements.
3.8 Maralvion does not represent, warrant or guarantee that Website content, ordering functionality, customer support, language support, safety communications, App links or other Website services will be available, lawful, complete, accurate or supported outside the countries where GlucoSensor™ Q is lawfully offered or supplied by Maralvion.
ARTICLE 4. NO MEDICAL ADVICE, DIAGNOSIS, TREATMENT OR EMERGENCY CARE THROUGH THE WEBSITE
4.1 Website content, product information, FAQs, tutorials, videos, articles, blogs, eBooks, newsletters, testimonials, reviews, advertisements, customer support communications and other information made available through or in connection with the Website are provided for general product information, educational, commercial, support or safety communication purposes only.
4.2 Nothing on the Website and nothing in any Website related communication from or on behalf of Maralvion should be interpreted as medical advice, diagnosis, treatment, a prescription, an instruction to use or change medication, an insulin dosing instruction, dietary advice, exercise advice or a recommendation to start, stop or change any medical treatment.
4.3 The Website, Website content and GlucoSensor™ Q must not be used to diagnose, screen for or rule out diabetes, prediabetes, gestational diabetes or any other medical condition. A diagnosis or medical assessment can only be made by a qualified healthcare professional on the basis of an appropriate clinical evaluation and, where required, laboratory testing or other clinically appropriate testing.
4.4 You must always seek the advice of a qualified healthcare professional if you have questions about your health, diabetes management, glucose levels, symptoms, medication, insulin use, treatment decisions, pregnancy, gestational diabetes or any medical condition.
4.5 You must never disregard professional medical advice, delay seeking medical advice or delay seeking emergency care because of Website content, product information, customer reviews, marketing materials, customer support communications, a missing response from customer support or any other Website related information.
4.6 If you use insulin, use glucose lowering medication, have recurring hypoglycaemia or hyperglycaemia, have impaired hypo awareness, are pregnant, have gestational diabetes, suspect that you may have gestational diabetes, have a relevant medical condition or have questions about whether GlucoSensor™ Q is suitable for you, you should use GlucoSensor™ Q only with appropriate medical guidance and consult a qualified healthcare professional where needed.
4.7 In the event of severe symptoms, suspected severe hypoglycaemia, suspected severe hyperglycaemia, suspected diabetic ketoacidosis, loss of consciousness, severe dehydration, confusion, seizures, chest pain, breathing difficulties or any other suspected medical emergency, you must seek immediate medical assistance and must not wait for Website information, Website availability, customer support, email, chat, forms, complaint handling or replacement handling.
4.8 In an emergency or suspected emergency, contact local emergency services directly, for example by calling 112 within the European Union, or contact a qualified healthcare professional or emergency healthcare facility directly.
4.9 Maralvion does not provide medical advice, clinical monitoring, diagnosis, treatment decisions, medication instructions, insulin dosing advice, emergency assistance or professional healthcare services through the Website.
ARTICLE 5. SAFE USE, IFU, PRODUCT LABELLING AND USER RESPONSIBILITY
5.1 You must use GlucoSensor™ Q and the App safely and only in accordance with the applicable product instructions, product labelling, App instructions, App warnings, safety notices and other product documentation made available to you.
5.2 Website content may assist users in finding, understanding or applying general product information, but it does not replace the IFU, product labelling, App warnings, safety notices or the advice of your treating healthcare professional.
5.3 You are responsible for reading and following instructions about product suitability, sensor placement, sensor activation, warm up, wear duration, replacement, removal, skin preparation, skin reactions, storage, handling, environmental conditions, compatible devices, alerts and safety warnings.
5.4 You must not use GlucoSensor™ Q if the sensor appears damaged, tampered with, expired, contaminated, incorrectly stored, incorrectly packaged, previously used or otherwise unsuitable for safe use.
5.5 You must stop using the sensor and seek appropriate advice if you experience significant skin irritation, allergic reaction, pain, bleeding, swelling, infection, detachment, sensor malfunction or any other issue that may affect safe use. If symptoms are severe, persistent or worsening, you must seek medical advice promptly.
5.6 Where fingerstick confirmation is required by the IFU, required by your healthcare professional or appropriate in your personal medical situation, you must use a conventional blood glucose meter and must not rely only on App information, Website content or customer support information.
5.7 You should keep an appropriate backup method available, including a conventional blood glucose meter and the supplies required to use it, where this is necessary for your personal medical situation, required by product instructions or advised by your healthcare professional.
5.8 GlucoSensor™ Q has not been specifically tested, clinically validated or approved for use during pregnancy or for gestational diabetes, unless the applicable IFU or product labelling expressly states otherwise. If you are pregnant, have gestational diabetes, suspect that you may have gestational diabetes or are being monitored for pregnancy related glucose concerns, you must not rely on Website content, GlucoSensor™ Q or the App as a substitute for pregnancy related diabetes care, professional medical supervision, clinically recommended glucose monitoring, laboratory testing or instructions from a qualified healthcare professional.
5.9 Before undergoing medical procedures, imaging procedures or treatments that may affect the sensor, the App or App readings, including MRI, CT, X ray, diathermy, radiation, strong electromagnetic fields or other relevant equipment or procedures, you must inform the healthcare professional involved that you are using GlucoSensor™ Q and follow applicable product instructions, product labelling, safety information and the instructions of the healthcare facility.
ARTICLE 6. WEBSITE CONTENT, EDUCATIONAL MATERIALS, TESTIMONIALS AND AVAILABILITY
6.1 Maralvion endeavours to keep Website content, product descriptions, product images, prices, availability information, delivery information, subscription information, support information and legal information accurate, complete and up to date.
6.2 Website content may nevertheless contain errors, omissions, typographical mistakes, translation inaccuracies, outdated information, incomplete information, incorrect availability information, incorrect pricing information or other inaccuracies.
6.3 Product images, screenshots, diagrams, videos, packaging images, lifestyle images and other visual materials are provided for general illustration and user understanding only and may differ from the actual product, packaging, App interface, language, display, accessories, compatible device environment, product version or regulatory documentation supplied to you.
6.4 Prices, promotions, discounts, subscription terms, stock availability, delivery times and shipping options may change and may be subject to restrictions, errors, corrections, eligibility requirements, country limitations, payment confirmation, stock availability and the applicable General Delivery Terms.
6.5 Educational materials, tutorials, blogs, articles, newsletters, product guides, user stories, testimonials, reviews, videos, advertisements, comparisons and FAQs are general, informational, educational, commercial or promotional in nature and must not be interpreted as personalized medical advice, clinical guidance, diagnosis, treatment or medication advice.
6.6 Testimonials, reviews, user stories and examples reflect individual experiences only and do not guarantee that you will experience the same results, suitability, accuracy, comfort, adherence, treatment outcome, health outcome, product experience or satisfaction.
6.7 If Website content conflicts with the IFU, product labelling, mandatory product information, App warnings or product safety notices, the IFU, product labelling, mandatory product information, App warnings or product safety notices shall prevail for that specific safety or product use matter.
6.8 If Website content conflicts with an order confirmation, the General Delivery Terms, the Returns and Refund Policy, the Sensor Replacement Policy or mandatory consumer rights, the applicable commercial document or mandatory right shall prevail for that specific matter.
6.9 All Website content is provided on an “as is” and “as available” basis, except to the extent mandatory law provides otherwise.
ARTICLE 7. CUSTOMER SUPPORT, PRODUCT COMPLAINTS AND SAFETY REPORTING
7.1 Customer support may assist with product related questions, Website use, App access questions, account issues, order related questions, delivery questions, returns, replacement requests, technical troubleshooting, complaints and safety related reporting.
7.2 Customer support is not a healthcare service and does not provide medical advice, diagnosis, treatment, clinical interpretation, medication advice, insulin dosing advice, emergency assistance, professional monitoring or medical triage.
7.3 You should contact Maralvion promptly if you experience a suspected product defect, sensor failure, App related safety issue, incorrect reading, skin reaction, unexpected product behaviour, Website related safety issue or another issue that may affect safe use.
7.4 When reporting a product issue, you may be asked to provide relevant information, such as product details, sensor details, App version, device type, operating system, screenshots, order details, event timing, symptoms, fingerstick comparison values, circumstances of use, photographs of packaging or the product and other information needed to assess the issue.
7.5 Where you choose to submit health related information, symptoms, fingerstick comparison values, screenshots or other potentially sensitive information through customer support, a complaint form, email or another Website related channel, Maralvion may process that information in accordance with the Privacy Policy and applicable medical device obligations.
7.6 Maralvion may use product complaint and safety related information to investigate issues, provide support, assess replacement requests, support vigilance obligations, cooperate with the Manufacturer, cooperate with the Authorised Representative and comply with applicable legal or regulatory obligations.
7.7 You must preserve relevant product information, packaging, batch information, App screenshots, sensor details, order details or other evidence where reasonably needed for complaint handling, safety assessment, replacement assessment or regulatory follow up.
7.8 Where you believe that a product issue may have caused or contributed to serious harm or a serious deterioration in health, you should report this promptly to Maralvion at support@glucosensor.com, so that the matter can be assessed and handled where required under applicable medical device law.
7.9 Reporting a complaint, suspected defect, adverse event or serious incident does not replace seeking medical care. If you have symptoms, urgent concerns or health related questions, you must seek appropriate medical advice or emergency assistance directly.
7.10 As seller and EU importer, Maralvion maintains a record of complaints and, where required or appropriate under applicable medical device law, forwards complaints, suspected non-conformities, suspected serious incidents and other relevant safety information to the Manufacturer and, where applicable, the Authorised Representative, and cooperates with them and with competent authorities.
ARTICLE 8. ACCOUNTS, E-COMMERCE, PAYMENTS, DELIVERY AND RETURNS
8.1 The Website may allow users to create or use an account for purposes such as ordering products, managing subscriptions, viewing order history, updating delivery information, contacting support, submitting replacement requests or accessing certain Website services.
8.2 Website accounts are intended for commercial, account, support and product communication purposes. A Website account does not create a medical monitoring relationship, healthcare provider relationship, emergency response relationship or obligation for Maralvion to monitor your health, App readings, glucose data, symptoms or condition.
8.3 You are responsible for providing accurate and up to date account, delivery, billing, contact, subscription and payment information.
8.4 You are responsible for keeping your account credentials, device access, login details, authentication factors and security settings confidential and secure, and must promptly take appropriate action if you suspect unauthorised access, account misuse, device compromise, loss of device, theft of device or a security breach.
8.5 Purchases, subscriptions, delivery, returns, refunds, replacements, cancellation rights, complaint handling and related commercial matters are governed by the General Delivery Terms, the Returns and Refund Policy, the Sensor Replacement Policy, the applicable order confirmation and any mandatory consumer rights that apply.
8.6 Maralvion may cancel, delay, refuse, suspend or correct orders where this is necessary or appropriate due to payment failure, suspected fraud, stock unavailability, incorrect pricing, incorrect product information, delivery restrictions, regulatory restrictions, unsupported destination, safety concerns, legal requirements or other circumstances described in the applicable commercial terms, subject to mandatory consumer rights.
8.7 Payment processing may be handled by external payment service providers. Maralvion does not store full payment card details where payments are processed by such external payment service providers.
8.8 Maralvion may store transaction references, payment status information, order information, accounting information, refund information and related administrative information where necessary for order processing, accounting, customer support, fraud prevention, legal compliance or the exercise of legal rights.
8.9 Delivery information, tracking information, customs information, fulfilment information and logistics updates may depend on external carriers, fulfilment providers, postal services, customs authorities, payment confirmation, stock availability, country restrictions and information provided by you.
8.10 Product returns and replacements may be subject to hygiene, safety, medical device, product integrity, packaging, evidence, timeframe and eligibility requirements as described in the Returns and Refund Policy, the Sensor Replacement Policy and mandatory law.
ARTICLE 9. PRIVACY, WEBSITE DATA AND NO ROUTINE STORAGE OF GLUCOSE DATA ON THE WEBSITE
9.1 The processing of Personal Data, Health Data and other personal information in connection with the Website is governed by the Privacy Policy. This Legal Disclaimer does not replace, limit or amend the Privacy Policy.
9.2 The Website may process account information, order information, delivery information, billing information, payment status information, subscription information, customer support information, replacement request information, complaint information, product safety reporting information, communication information, Website usage information, cookie information and other information described in the Privacy Policy.
9.3 As part of normal Website operation, the Website does not provide, display, calculate, interpret, monitor or routinely store real time or historical CGM readings, glucose trends, glucose alerts, glucose reports or other medical measurement data generated by the Sensor, the App or the GlucoSensor™ Q System.
9.4 The Website is not a portal for clinical monitoring of glucose data and Maralvion does not use the Website to monitor your health, glucose values, symptoms, alerts, trends or condition.
9.5 The fact that you purchase, request information about, request support for or submit a complaint concerning a medical device may reveal information about your health interests, possible health status or product use. Such information is handled in accordance with the Privacy Policy and applicable law.
9.6 If you voluntarily provide health related information, symptoms, fingerstick comparison values, screenshots, photographs, App information, Sensor information or other sensitive information through a Website form, email, chat, customer support channel, complaint channel or replacement request channel, Maralvion may process that information to provide support, assess complaints, assess replacement requests, investigate safety issues, cooperate with the Manufacturer or Authorised Representative, comply with medical device obligations, comply with legal obligations or exercise legal rights, as described in the Privacy Policy.
9.7 You must ensure that the contact details linked to your account or order are accurate and up to date, so that important product, safety, account, order, App or regulatory communications can reach you.
9.8 Nothing in this Legal Disclaimer limits, excludes or replaces any rights, remedies, obligations or protections under applicable data protection law.
ARTICLE 10. COOKIES, THIRD-PARTY SERVICES, LINKS AND TRANSLATIONS
10.1 The Website may use cookies, pixels, local storage, tags, scripts, analytics tools, advertising technologies and similar technologies to operate the Website, remember user preferences, support security, process orders, measure Website performance, analyse Website use, improve services and support marketing activities.
10.2 Information about cookies and similar technologies, their purposes, legal bases, retention periods, third-party providers and your choices is provided in the Privacy Policy, cookie notice or cookie consent interface made available on the Website.
10.3 Where consent is required by applicable law, non-essential cookies and similar technologies will be subject to your consent through the applicable cookie consent mechanism.
10.4 Blocking or disabling certain cookies, trackers, scripts or browser technologies may affect Website functionality, account access, checkout, payment, security, language settings, analytics, embedded content, customer support tools or other Website features.
10.5 The Website may contain links, references, integrations, embeds or redirects to third-party websites, services, resources, platforms, payment providers, authentication providers, logistics providers, app stores, analytics providers, marketing platforms, video platforms, review platforms, social media platforms, translation tools or other external services.
10.6 Third-party services are not operated, controlled or managed by Maralvion and may be subject to separate terms, privacy notices, cookie notices, availability limitations, security practices, technical limitations, content standards, data processing practices, jurisdictional restrictions and changes outside the direct control of Maralvion.
10.7 The presence of a third-party link, integration, logo, embedded tool or service on the Website does not constitute medical advice, endorsement, approval, affiliation, validation, warranty or guarantee by Maralvion, unless expressly stated otherwise.
10.8 The Website may use or support automated or third-party translation technology. Translations may contain inaccuracies, omissions, wording differences, terminology differences or context errors and must be interpreted in accordance with Article 18.
ARTICLE 11. AI, AUTOMATED TOOLS, USER-GENERATED CONTENT AND REVIEWS
11.1 The Website may provide or reference questionnaires, product selectors, decision aids, calculators, eligibility tools, chatbots, automated support tools, AI generated content, AI assisted search, AI assisted summaries or similar automated tools.
11.2 Such tools are intended only for general information, user convenience, commercial support, navigation, education or non medical product support.
11.3 No questionnaire, product selector, decision aid, calculator, chatbot, AI output, automated recommendation or similar tool on the Website should be interpreted as medical advice, diagnosis, screening, clinical assessment, treatment guidance, medication advice, insulin dosing advice, dietary advice, exercise advice or a professional determination that GlucoSensor™ Q is suitable for you.
11.4 Automated tools may be incomplete, inaccurate, outdated, based on limited input, affected by technical errors, affected by assumptions, affected by translation errors or unsuitable for your personal medical situation.
11.5 The Website may allow users to submit reviews, testimonials, comments, questions, ratings, photographs, support information, complaint information or other user-generated content.
11.6 You are solely responsible for user-generated content that you submit, upload, publish or transmit through the Website, and you must not submit unlawful, defamatory, misleading, infringing, offensive, discriminatory, abusive, threatening, harmful, fraudulent, spam, malicious, privacy violating, confidential, inappropriate or otherwise unlawful content.
11.7 You should not include unnecessary health information, glucose data, medical history, medication details, personal identification numbers, payment details, login details or other sensitive information in public reviews, comments, testimonials or community areas.
11.8 User reviews, testimonials, comments and community content are not medical advice, professional guidance, clinical evidence or product safety instructions and may be incomplete, inaccurate, subjective, outdated or not applicable to your situation.
11.9 Maralvion may moderate, refuse, edit, remove, restrict, report or disable user-generated content where appropriate to protect users, comply with law, protect product safety, prevent misleading information, protect privacy, protect intellectual property, enforce Website terms or maintain the integrity of the Website.
ARTICLE 12. INTELLECTUAL PROPERTY AND PROHIBITED USE
12.1 All intellectual property rights in the Website and its content, including texts, graphics, images, trademarks, logos, product names, trade names, user interfaces, videos, documentation, software elements, design elements, databases, product information and other proprietary materials, are owned by Maralvion, the Manufacturer, their group companies or their respective licensors, unless expressly stated otherwise.
12.2 You may access and use Website content only for personal, non-commercial, lawful purposes related to learning about, purchasing, using or receiving support for GlucoSensor™ Q, unless Maralvion has expressly authorised another use in writing.
12.3 You must not copy, reproduce, modify, translate, scrape, crawl, extract, publicly display, distribute, license, publish, sell, create derivative works from, reverse engineer or otherwise exploit Website content without prior written permission from Maralvion, except where such restriction is not permitted under mandatory law.
12.4 You must not use Maralvion’s trademarks, trade names, product names, logos, domain names, product images, packaging images, regulatory materials or other proprietary identifiers without prior written permission from Maralvion, except where such use is permitted by mandatory law.
12.5 You must not use the Website in a way that may compromise product safety, cybersecurity, Website functionality, data integrity, account security, another user’s rights or compliance with applicable law.
12.6 You must not disrupt, compromise, overload, reverse engineer, scan, scrape, bypass, interfere with, gain unauthorised access to or misuse the Website, Website accounts, security features, payment flows, customer support systems, databases or technical infrastructure.
12.7 You must not use the Website, Website content or Website services for unlawful purposes, misleading purposes, fraudulent purposes, unauthorised commercial use, unauthorised data extraction, professional medical monitoring without authorisation or any purpose that may endanger users or third parties.
ARTICLE 13. WEBSITE AVAILABILITY, CYBERSECURITY AND TECHNICAL INTERRUPTIONS
13.1 Maralvion endeavours to provide a secure, reliable and functional Website, but does not guarantee that the Website, Website account functionality, ordering functionality, support forms, downloads, translations, embedded tools, payment redirects, customer support tools or other Website services will always be available, uninterrupted, error free, secure or free from harmful components.
13.2 Website functionality may be affected by maintenance, updates, hosting issues, internet connectivity, third-party services, payment providers, authentication providers, logistics integrations, analytics tools, translation tools, security measures, cyber incidents, software errors, browser settings, device settings, operating system behaviour, user configuration or other factors outside the direct control of Maralvion.
13.3 Website outages, errors, delays or technical interruptions may result in delayed access to information, failed checkout, delayed customer support communication, delayed complaint submission, delayed replacement request submission, unavailable downloads, incomplete form submissions or other inconvenience.
13.4 You must not rely on the Website, Website availability, customer support forms, email, chat, account access or online information for urgent medical needs, emergency situations or immediate health related decisions.
13.5 You are responsible for using secure devices, secure networks, updated browsers, appropriate antivirus protection, strong passwords, secure authentication methods and reasonable cybersecurity practices when accessing the Website.
13.6 Maralvion may take security measures, suspend access, restrict functionality, block suspicious activity, apply rate limits, request additional verification or make technical changes where appropriate to protect product safety, users, personal data, Website security, legal compliance or regulatory compliance.
ARTICLE 14. PRODUCT SAFETY COMMUNICATIONS, RECALLS AND REGULATORY INFORMATION
14.1 The Website may be used to make available product safety information, IFU access information, App update information, compatibility information, cybersecurity information, field safety notices, recall notices, mandatory product communications, regulatory information, support instructions or other safety related communications.
14.2 Product safety communications may also be provided through email, account notifications, Website notices, App notices, customer support channels, packaging inserts or other appropriate communication channels.
14.3 Safety notices, field safety notices, recall notices, mandatory product communications, App update notices, cybersecurity notices, regulatory communications and other safety related communications are not marketing communications and may be sent or displayed where required or appropriate for product safety, user safety, cybersecurity, regulatory compliance or legal compliance.
14.4 You must not ignore safety related communications, product notices, App warnings, recall notices, cybersecurity notices or instructions relating to the safe use of GlucoSensor™ Q.
14.5 If a safety notice, field safety notice, recall notice or other mandatory product communication instructs you to stop using a product, check batch information, return a product, preserve a product, contact support, update the App, replace a Sensor, change settings or take another action, you must follow that instruction and seek medical advice where appropriate.
14.6 Maralvion may update, amend, withdraw, replace or supplement product information on the Website in response to safety information, manufacturer information, regulatory requirements, product changes, App changes, field safety corrective actions, cybersecurity requirements or other relevant developments.
ARTICLE 15. LIABILITY LIMITATIONS AND MANDATORY RIGHTS
15.1 This Legal Disclaimer explains important limitations of the Website and clarifies user responsibility. It is not intended to exclude liability where liability cannot be excluded under mandatory law.
15.2 Nothing in this Legal Disclaimer, and nothing in the provision of Website content, product information, educational content, tutorials, customer support, ordering functionality, account functionality, reviews, automated tools or other Website services, creates any duty on the part of Maralvion to monitor your glucose data, your health or your condition, or to detect, interpret, notify, escalate or respond to any glucose value, trend, alert, missing alert, symptom or medical condition.
15.3 Responsibility for monitoring your glucose levels and acting on them remains with you and, where applicable, your treating healthcare professional. This does not limit or exclude any liability that cannot be limited or excluded under mandatory law.
15.4 To the fullest extent permitted by applicable law, Maralvion shall not be responsible for loss, damage, injury, health related consequences, data related consequences, commercial consequences or other consequences resulting from your failure to follow applicable product instructions, Website warnings, App warnings, safety notices, professional medical advice or the requirements set out in this Legal Disclaimer.
15.5 To the fullest extent permitted by applicable law, Maralvion shall not be responsible for consequences resulting from reliance on Website content, customer support, automated tools, reviews, testimonials, tutorials, product descriptions, advertisements or other Website information where fingerstick confirmation, medical advice, emergency care, IFU compliance or other appropriate action was required.
15.6 To the fullest extent permitted by applicable law, Maralvion shall not be responsible for consequences resulting from inaccurate, incomplete, delayed, missing, interrupted, unavailable, outdated, mistranslated, misinterpreted or unverified Website content, or from technical failures, connectivity issues, hosting interruptions, third-party service interruptions, payment provider issues, authentication provider issues, translation tool errors, user device issues, user settings, user configuration, user inattention or factors outside its direct control, except where liability cannot be limited or excluded under mandatory law.
15.7 To the fullest extent permitted by applicable law, Maralvion shall not be responsible for consequences resulting from unauthorised access, compromised accounts, shared credentials, user security failures, prohibited use, unlawful use, misuse of the Website, misuse of Website content or use of the Website outside its intended purpose, except where liability cannot be limited or excluded under mandatory law.
15.8 Nothing in this Legal Disclaimer excludes or limits liability, rights, remedies, obligations or protections to the extent that such exclusion or limitation is not permitted under mandatory applicable law.
15.9 Nothing in this Legal Disclaimer limits, excludes or replaces any rights you may have under mandatory consumer protection law, product liability law, data protection law, medical device law or any other mandatory legal provision.
15.10 Maralvion remains responsible only to the extent mandatory applicable law imposes responsibility on Maralvion within its own role. This Legal Disclaimer does not extend Maralvion’s role beyond the roles expressly described in the Website EULA and Terms of Use, the App EULA, this Legal Disclaimer and applicable product documentation.
15.11 The limitations in this Legal Disclaimer apply only to the extent permitted by applicable law and shall be interpreted as narrowly as necessary to remain valid and enforceable.
ARTICLE 16. ISSUER, MANUFACTURER INFORMATION, IFU AND CONTACT
16.1 This Legal Disclaimer is issued by Maralvion sp. z o.o., acting as the seller and EU importer of GlucoSensor™ Q.
16.2 Maralvion has its registered office at Pl. Władysława Andersa 3, 11th Floor, 61-894 Poznań, Poland, and is registered in the Polish National Court Register under KRS 0001235440.
16.3 Maralvion can be contacted through www.glucosensor.com or by email at support@glucosensor.com.
16.4 This Legal Disclaimer applies to the Website and Website related services. It does not create or alter the regulatory roles and responsibilities of the Manufacturer, the Authorised Representative or Maralvion under applicable medical device law.
16.5 GlucoSensor™ Q is an OEM branded Continuous Glucose Monitoring device, Model D1, manufactured by Dreisam (Beijing) Medical Technology Co., Ltd. The Authorised Representative of the Manufacturer in the European Union is Firsteck Bio S.r.l., Via Salvatore Quasimodo 36/38, 40013 Castel Maggiore, Italy. The full regulatory identification details of the Manufacturer, the Authorised Representative, the certified device model and the applicable regulatory information are identified in the manufacturer approved regulatory documentation, product labelling, product packaging and, where applicable, mandatory product information made available through the App or the Website.
16.6 The IFU is supplied in paper form with each GlucoSensor™ Q sensor package. You must read the IFU before using the sensor. If you cannot find the IFU, cannot read it, do not understand it or require an additional copy, you should contact Maralvion at support@glucosensor.com before using or continuing to use GlucoSensor™ Q. Where reasonably required, a replacement paper copy of the applicable IFU may be requested free of charge. Where available, Maralvion may also provide access to the IFU through the Website, customer support channels or other appropriate means.
16.7 Questions about this Legal Disclaimer, the Website or the use of GlucoSensor™ Q may be submitted through www.glucosensor.com or by email at support@glucosensor.com.
16.8 Suspected product defects, Website related safety issues, App related safety issues or other concerns relating to the safe use of GlucoSensor™ Q should be reported promptly to Maralvion at support@glucosensor.com, unless applicable product instructions or applicable law require reporting through another channel.
ARTICLE 17. AMENDMENTS AND UPDATES TO THIS LEGAL DISCLAIMER
17.1 Maralvion may amend, update or replace this Legal Disclaimer where this is necessary or appropriate due to changes in applicable law, medical device requirements, regulatory guidance, product documentation, Website functionality, App functionality, safety information, technical requirements, cybersecurity requirements, app store requirements, e-commerce processes, payment processes, logistics processes, customer support processes or business processes.
17.2 Any amendment to this Legal Disclaimer shall not reduce, restrict or exclude any mandatory rights that you may have under applicable consumer protection law, product liability law, data protection law, medical device law or any other mandatory legal provisions.
17.3 Where an update to this Legal Disclaimer is material, Maralvion will take reasonable steps to inform users through one or more appropriate communication channels, including the Website, the App, email, customer account notifications, checkout notices, support channels or other suitable means.
17.4 Continued use of the Website after an updated version of this Legal Disclaimer has been made available may be subject to your acceptance of the updated version, where acceptance is required by the Website, by applicable law or by the nature of the update.
17.5 Maralvion may issue safety notices, field safety notices, recall notices, mandatory product information, Website update notices, App update notices, cybersecurity notices or other legally required communications separately from this Legal Disclaimer. Such communications may apply immediately where required for product safety, user safety, regulatory compliance or legal compliance.
17.6 You are responsible for reviewing safety related information, Website notices, App notices and product communications made available to you. You must not ignore safety related updates, warnings or instructions.
ARTICLE 18. LANGUAGE, INTERPRETATION AND OTHER LEGAL DOCUMENTS
18.1 This Legal Disclaimer has been drafted in English.
18.2 Maralvion may make translations or local-language versions of this Legal Disclaimer available through the Website, Website functionality, customer support, translation functionality or other communication channels for user convenience, Website functionality, market access, customer information, accessibility or compliance support.
18.3 To the extent permitted by mandatory applicable law, the English version is the leading and controlling version for interpretation where there is an ambiguity, discrepancy or inconsistency between the English version and any translated or local-language version of this Legal Disclaimer.
18.4 Translated and local-language versions should be interpreted consistently with the English version as far as legally possible. If a translated or local-language version appears unclear, incomplete or inconsistent, Maralvion may correct, update or clarify that version.
18.5 Articles 18.2 to 18.4 do not exclude or reduce mandatory local consumer protection requirements, medical device language requirements, data protection transparency requirements or national rules governing the language in which contractual, consumer, privacy, product or safety information must be supplied, interpreted or made available.
18.6 Where a linguistic discrepancy concerns safe or correct use, intended purpose, indications, contraindications, warnings, precautions, product performance, product labelling, the IFU, App warnings, mandatory regulatory information or safety notices, the applicable manufacturer-approved IFU, product labelling, mandatory regulatory information and safety notices supplied in the language required by applicable law prevail for that specific matter.
18.7 If you do not understand this Legal Disclaimer, the IFU, product labelling, Website content, App warnings, safety notices or any other product-related information, you must not rely on assumptions. You should seek clarification and, where the question relates to your health, diabetes management, treatment, medication, insulin use, symptoms or medical condition, you should consult a qualified healthcare professional.
18.8 This Legal Disclaimer should be read together with the related legal documents, product information and safety information identified in Article 1.3, where applicable. In the event of any inconsistency between this Legal Disclaimer and another legal document, the order of precedence set out in Article 1 shall apply.
18.9 Questions concerning governing law, jurisdiction, dispute resolution, Website account use, suspension, termination and other general legal terms relating to use of the Website are governed by the Website EULA and Terms of Use. Questions concerning purchases, subscriptions, delivery, payment, cancellation, returns, refunds, replacements, commercial complaints and related commercial terms are governed by the General Delivery Terms, the Returns and Refund Policy and the Sensor Replacement Policy, as applicable.
18.10 If any provision of this Legal Disclaimer is held to be invalid, unlawful or unenforceable, that provision shall be interpreted as narrowly as necessary to remain valid and enforceable to the fullest extent permitted by applicable law. The remaining provisions shall remain in force to the fullest extent permitted by applicable law.